A Survey of the Prevalence and Impact of Reporting Guideline Endorsement in Pathology Journals

作者：Caron Justin E; March Jordon K; Cohen Michael B; Schmidt Robert L^*

来源：American Journal of Clinical Pathology, 2017, 148(4): 314-322.

DOI：10.1093/AJCP/AQX080

• Prognosis
• Biomarkers
• REMARK
• Quality
• Reporting
• Guideline

Objectives: To determine the prevalence of reporting guideline endorsement in pathology journals and to estimate the impact of guideline endorsement.
Methods: We compared the quality of reporting in two sets of studies: (1) studies published in journals that explicitly mentioned a guideline vs studies published in journals that did not and (2) studies that cited a guideline vs studies that did not. The quality of reporting in prognostic biomarker studies was assessed using the REporting recommendations for tumor MARKer prognostic studies (REMARK) guideline.
Results: We found that six (10%) of the 59 leading pathology journals explicitly mention reporting guidelines in the instructions to authors. Only one journal required authors to submit a checklist. There was significant variation in the rate at which various REMARK items were reported (P<.001). Journal endorsement was associated with more complete reporting (P=.04). Studies that cited REMARK had greater adherence to the REMARK reporting guidelines than studies that did not (P=.02).
Conclusions: The prevalence of guideline endorsement is relatively low in pathology journals, but guideline endorsement may improve the quality of reporting.

• 出版日期2017-10